Inspire Medical Systems, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD 77.92 M

Inspire Medical Systems, Inc. EBITDA is USD 77.92 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -380.96% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Inspire Medical Systems, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -27.73 M, a -40.56% change year over year.
  • Inspire Medical Systems, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -46.66 M, a 21.31% change year over year.
  • Inspire Medical Systems, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -38.47 M, a -28.77% change year over year.
  • Inspire Medical Systems, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -54.00 M, a 40.28% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)